Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Fidelity Disruptive Medicine ETF
Similar ETFs
Trading data
FMED performance and flow charts
Performance
Flows
Historic performance and flows
Data as of March 17, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | -3.98% | -8.74% | -8.56% | +1.03% | ||
| Flows | - | - | - | +$5M | - | - |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +18.95% | +19.91% | ||
Max drawdown | -14.72% | -15.97% | ||
Max drawdown duration | 54d | 107d | N/A | N/A |
Time to recover | N/A | N/A | N/A | N/A |
Exposure
Data as of January 31, 2026Countries
Sectors
Diversification
Total weight of top 15 holdings out of 65
Top 15 Holdings
Characteristics
This share class generates a stream of income by distributing dividends.
| Management strategy | Active |
| Provider | Fidelity |
| N° of holdings | 65 |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | June 12, 2023 |
| ESG | No |
What type of ETF is FMED?
FMED is a Active ETF that provides exposure to Equity assets. It is managed by Fidelity.
What does FMED invest in?
This ETF provides exposure to Other Equities. It is part of the segment: Multiple Trends.
What is the expense ratio of FMED?
The total expense ratio (TER) of FMED is 0.5%, representing the annual fee charged by the fund manager.
When was FMED launched?
FMED was launched on June 12, 2023, marking its entry into the ETF market.
Who is the issuer of FMED?
FMED is issued by Fidelity.
What is the AUM of FMED?
As of March 17, 2026, FMED manages $57.57 M, reflecting the total assets held in the fund.
How has FMED performed recently?
As of March 17, 2026, FMED delivered a return of -3.98% over the past month (1M performance), -8.74% over the past three months (3M), and -8.56% year-to-date (YTD).
How many holdings are in FMED
As of January 31, 2026, FMED holds 65 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is FMED?
As of January 31, 2026, FMED holds 65 securities, with 47.79% of its assets concentrated in its top 15 holdings.
What are the top holdings of FMED?
As of January 31, 2026, FMED holds a portfolio of 65 underlyings, with its largest positions including BOSTON SCIENTIFIC, DANAHER and US04016X1019. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does FMED invest in?
As of January 31, 2026, FMED has its largest geographic exposures in USA.
What sectors or themes does FMED focus on?
As of January 31, 2026, FMED is primarily exposed to Health Care.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - Rethinking the 60/40 with Alternatives, Thematics
Christian Magoon, Founder and CEO of Amplify ETFs joins The ETF Show to discuss how alternative strategies and thematics are replacing bonds in the 60/40 portfolio.
ETF Trends
ETF Industry KPIs March 16, 2026
The ETF industry saw 22 new launches and 1 closure last week.
Asset TV
The ETF Show - Markets Remain Resilient Despite US-Iran War
Simeon Hyman, Global Investment Strategist at ProShares joins The ETF Show to discuss the market reaction to the US-Iran war, the market rotation, and the need for quality in investor portfolios.
Asset TV
The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring
Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.
Browse all educational columns
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
